Evidence map›Paper›PMID 39280239›Full record

ArticleJournal of medical imaging (Bellingham, Wash.)2024

Radiomics and quantitative multi-parametric MRI for predicting uterine fibroid growth.

Karen Drukker, Milica Medved, Carla B Harmath, Maryellen L Giger, Obianuju S Madueke-Laveaux

Abstract read
In one paragraph

Article in Journal of medical imaging (Bellingham, Wash.), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Karen DrukkerUniversity of Chicago, Department of Radiology, Chicago, Illinois, United States.ORCID https://orcid.org/0000-0001-6544-3476
Milica MedvedUniversity of Chicago, Department of Radiology, Chicago, Illinois, United States.ORCID https://orcid.org/0000-0003-2945-5511
Carla B HarmathUniversity of Chicago, Department of Radiology, Chicago, Illinois, United States.
Maryellen L GigerUniversity of Chicago, Department of Radiology, Chicago, Illinois, United States.ORCID https://orcid.org/0000-0001-5482-9728
Obianuju S Madueke-LaveauxUniversity of Chicago, Department of Obstetrics and Gynecology, Chicago, Illinois, United States.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Significance: Uterine fibroids (UFs) can pose a serious health risk to women. UFs are benign tumors that vary in clinical presentation from asymptomatic to causing debilitating symptoms. UF management is limited by our inability to predict UF growth rate and future morbidity. Aim: We aim to develop a predictive model to identify UFs with increased growth rates and possible resultant morbidity. Approach: We retrospectively analyzed 44 expertly outlined UFs from 20 patients who underwent two multi-parametric MR imaging exams as part of a prospective study over an average of 16 months. We identified 44 initial features by extracting quantitative magnetic resonance imaging (MRI) features plus morphological and textural radiomics features from DCE, T2, and apparent diffusion coefficient sequences. Principal component analysis reduced dimensionality, with the smallest number of components explaining over 97.5% of the variance selected. Employing a leave-one-fibroid-out scheme, a linear discriminant analysis classifier utilized these components to output a growth risk score. Results: The classifier incorporated the first three principal components and achieved an area under the receiver operating characteristic curve of 0.80 (95% confidence interval [0.69; 0.91]), effectively distinguishing UFs growing faster than the median growth rate of Conclusion: We developed a promising predictive model utilizing quantitative MRI features and principal component analysis to identify UFs with increased growth rates. Furthermore, the model's discrimination ability supports its potential clinical utility in developing tailored patient and fibroid-specific management once validated on a larger cohort.

Indexed as

artificial intelligencemachine learningmulti-parametric magnetic resonance imagingradiomicsuterine fibroidswomen’s health

Identifiers

PMID39280239
PMCPMC11391479

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.